This site is intended for healthcare professionals only
LoginRegister

Nephrology Dialogues

FDA approves Semaglutide for renal protection among diabetes patients with CKD

FDA approves Semaglutide for renal protection among diabetes patients with CKD

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
View All

Latest News and Guidelines

Study Sheds Light on Effect of Cholesterol Lowering Drugs on Kidney Function

Study Sheds Light on Effect of Cholesterol Lowering Drugs on Kidney Function

Age, gender, and method of catheter implantation influence Inflow and Drain Pain After Peritoneal Dialysis: Study

Age, gender, and method of catheter implantation influence Inflow and Drain Pain After Peritoneal...

Novo Nordisk Ozempic get USFDA nod

Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular...

Old Age, High NWR, and PCT may Predict Mortality in Hemodialysis Patients with COVID-19, suggests study

Old Age, High NWR, and PCT may Predict Mortality in Hemodialysis Patients with COVID-19, suggests...

Proteinuria following administration of immune check point inhibitor

Study Highlights Risk of Proteinuria in Patients Receiving Immune Checkpoint Inhibitors

Prone Position More Effective for Treating Proximal Ureteral Stones with Shock Wave Lithotripsy, finds study

Prone Position More Effective for Treating Proximal Ureteral Stones with Shock Wave Lithotripsy,...

View All
X